Hayato Nakabayashi

Dr. Hayato Nakabayashi


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2025 in Viruses
Verified
Journal Article
Open access
PDF file
HNHayato Nakabayashi
Hayato Nakabayashi
JYJunko Yamaguchi
Junko Yamaguchi
KTKen Takahashi
Ken Takahashi
YKYasuyoshi Kai
Yasuyoshi Kai
Kosaku KinoshitaKosaku Kinoshita
Kosaku Kinoshita
This single-center retrospective observational study investigated the association between changes in body composition during hospitalization and outcomes in patients with severe coronavirus disease (COVID-19) pneumonia. Body composition was assessed using chest computed tomography (CT) within 3 days of intensive care unit admission and follow-up CT within 14 days. The study population comprised 89 adult patients, among whom 57 survived. The median APACHE II score on admission was 16. Initial CT scans showed that the iliopsoas muscle volume, sum of the pectoralis major and minor muscle areas, and erector spinae muscle (ESM) area were significantly larger in survivors than in non-survivors (p = 0.019, 0.011, and 0.001, respectively). Subcutaneous fat tissue (SAT) volume was higher in survivors (p = 0.003), and the rate of change in the SAT volume was lower in survivors (p = 0.043). Multivariate logistic regression analysis revealed that a high APACHE II score (OR: 0.834, 95% CI: 0.741–0.938, p = 0.002) and small ESM area (OR: 1.001, 95% CI: 1.000–1.002, p = 0.031) were independent predictors of mortality. In conclusion, the loss of supporting respiratory muscles, particularly ESM, may play a critical role beyond general acute sarcopenia, and the preserved SAT in non-survivors may reflect abnormal glucose metabolism due to severe inflammation.

15 July 2026 in Medical Sciences
Verified
Journal Article
Open access
PDF file
YYYurina Yamaya
Yurina Yamaya
TKTsukasa Kuwana
Tsukasa Kuwana
Kosaku KinoshitaKosaku Kinoshita
Kosaku Kinoshita
KTKen Takahashi
Ken Takahashi
HNHayato Nakabayashi
Hayato Nakabayashi
ITImai Toru
Imai Toru
Background/Objectives: Septic shock carries high mortality. Although guidelines recommend early empiric antibiotics, early identification of the infection source and selection of appropriate initial antibiotic therapy remain challenging. This study examined whether vasopressor trajectories, quantified as norepinephrine equivalent (NEE), differed according to initial antimicrobial susceptibility and concordance between presumed and final infection sources. Methods: This single-center retrospective observational study included adults with Sepsis-3 septic shock admitted to the intensive care unit between 2017 and 2023. Patients were classified into the appropriate-management group when the initial antibiotic therapy covered the subsequently identified causative pathogen and the initially presumed infection source was concordant with the final infection source; all others were classified into the inappropriate-management group. Primary outcomes were Max NEE duration and the times from Max NEE to 75%, 50%, 25%, and discontinuation of NEE. Results: Among 132 patients analyzed, 101 were classified into the appropriate-management group and 31 into the inappropriate-management group. Max NEE duration was shorter in the appropriate-management group (median (IQR), 4 (2–7) h vs. 6 (3–20) h; p = 0.0100) and remained shorter after excluding deaths during the Max NEE period (n = 119; 6 (2–11) h vs. 11 (5–14) h; p = 0.0314). Time to NEE reduction from Max NEE was shorter in the appropriate-management group, with significant differences at 75% (7 (4–13) h vs. 13 (9–23) h; p = 0.0066) and 25% (19 (13–29) h vs. 31 (16–46) h; p = 0.0247). Conclusions: Prolonged Max NEE duration and delayed NEE reduction were associated with inadequate coverage by initial antibiotic therapy or discordant infection source identification in this selected cohort. Vasopressor trajectories may help prompt reassessment of antibiotic therapy and infection source evaluation.

19 November 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KTKen Takahashi
Ken Takahashi
JYJunko Yamaguchi
Junko Yamaguchi
HNHayato Nakabayashi
Hayato Nakabayashi
Kosaku KinoshitaKosaku Kinoshita
Kosaku Kinoshita
Background/Objectives: Failure to recognize high-flow nasal cannula (HFNC) failure early may delay intubation and worsen clinical outcomes. We investigated whether the early physiological response to HFNC and erector spinae muscle (ESM) area at admission were associated with HFNC failure in pneumonia-related acute respiratory failure. Methods: This single-center retrospective observational cohort study included adults who received HFNC within 24 h of intensive care unit admission between 2019 and 2023. HFNC failure was defined as intubation within 7 days. The Respiratory Rate–Oxygenation (ROX) index was measured before HFNC initiation. For days 1 and 2, the best response ROX index was retrospectively defined as the ROX value corresponding to the highest PaO2/ fraction of inspired oxygen ratio within each 24 h assessment window, rather than as a measurement obtained at a prespecified time point. The ESM area at T12 was measured on admission. Longitudinal changes in the ROX index and factors associated with HFNC failure were evaluated. Results: Among 94 patients, 21 experienced HFNC failure. The admission ROX index did not differ significantly between the groups (3.4 versus 3.6). The median best response ROX indices in the success and failure groups were 10.7 versus 6.6 on day 1 and 10.5 versus 6.4 on day 2. ROX improvement was significantly smaller in the failure group on both days. The day 1 best response ROX index had an area under the receiver operating characteristic curve of 0.731 (95% confidence interval [CI], 0.611–0.851). In the primary analysis using Firth penalized logistic regression (85 patients, including 17 HFNC failures), a lower day 1 best response ROX index (adjusted odds ratio [OR] per unit increase, 0.818; 95% CI, 0.692–0.931) and a smaller admission ESM area (adjusted OR per 100 mm2 increase, 0.939; 95% CI, 0.872–0.999) were associated with HFNC failure. Conclusions: The day 1 best response ROX index and admission ESM area were associated with HFNC failure. However, their clinical utility remains uncertain, and prospective multicenter studies with standardized assessment protocols and external validation are warranted.